Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS).
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
This position will develop, direct, execute and lead the strategic sales business strategy that positions our product portfolio for accelerated growth in the IDN customer segment of our business. Strengthen our market position through unique contracting and pricing strategies that create competitive advantages for the product portfolio while continuously enhancing market knowledge & expertise on the changing healthcare landscape.